Boris Peaker
Stock Analyst at TD Cowen
(1.83)
# 3,027
Out of 4,711 analysts
22
Total ratings
33.33%
Success rate
5.57%
Average return
Main Sectors:
Stocks Rated by Boris Peaker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AADI Aadi Bioscience | Downgrades: Hold | n/a | $3.39 | - | 2 | Aug 21, 2024 | |
| GLYC GlycoMimetics | Downgrades: Hold | n/a | $0.23 | - | 1 | Jul 26, 2024 | |
| MGNX MacroGenics | Downgrades: Hold | n/a | $3.18 | - | 3 | May 10, 2024 | |
| LNTH Lantheus Holdings | Initiates: Outperform | $100 | $89.29 | +12.00% | 1 | Dec 4, 2023 | |
| ADCT ADC Therapeutics | Downgrades: Market Perform | n/a | $1.96 | - | 1 | Nov 9, 2023 | |
| PCRX Pacira BioSciences | Upgrades: Outperform | $50 | $18.98 | +163.44% | 1 | Aug 3, 2023 | |
| PCVX Vaxcyte | Initiates: Outperform | n/a | $86.53 | - | 1 | Apr 18, 2023 | |
| XNCR Xencor | Initiates: Outperform | n/a | $24.13 | - | 1 | Dec 6, 2022 | |
| EBS Emergent BioSolutions | Maintains: Market Perform | $30 → $29 | $8.10 | +258.02% | 1 | Sep 12, 2022 | |
| CTMX CytomX Therapeutics | Downgrades: Market Perform | n/a | $1.09 | - | 2 | Jul 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $95 → $102 | $98.05 | +4.03% | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $0.93 | - | 1 | Mar 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $1.21 | - | 1 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.97 | - | 1 | Aug 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $12.46 | - | 1 | Jul 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.88 | - | 1 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.60 | - | 1 | Jul 24, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $623.82 | - | 1 | Jun 12, 2017 |
Aadi Bioscience
Aug 21, 2024
Downgrades: Hold
Price Target: n/a
Current: $3.39
Upside: -
GlycoMimetics
Jul 26, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.23
Upside: -
MacroGenics
May 10, 2024
Downgrades: Hold
Price Target: n/a
Current: $3.18
Upside: -
Lantheus Holdings
Dec 4, 2023
Initiates: Outperform
Price Target: $100
Current: $89.29
Upside: +12.00%
ADC Therapeutics
Nov 9, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $1.96
Upside: -
Pacira BioSciences
Aug 3, 2023
Upgrades: Outperform
Price Target: $50
Current: $18.98
Upside: +163.44%
Vaxcyte
Apr 18, 2023
Initiates: Outperform
Price Target: n/a
Current: $86.53
Upside: -
Xencor
Dec 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $24.13
Upside: -
Emergent BioSolutions
Sep 12, 2022
Maintains: Market Perform
Price Target: $30 → $29
Current: $8.10
Upside: +258.02%
CytomX Therapeutics
Jul 11, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $1.09
Upside: -
Jun 27, 2022
Maintains: Market Perform
Price Target: $95 → $102
Current: $98.05
Upside: +4.03%
Mar 15, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $0.93
Upside: -
Mar 3, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $1.21
Upside: -
Aug 13, 2021
Initiates: Outperform
Price Target: n/a
Current: $2.97
Upside: -
Jul 29, 2021
Initiates: Outperform
Price Target: n/a
Current: $12.46
Upside: -
Oct 22, 2018
Initiates: Outperform
Price Target: n/a
Current: $1.88
Upside: -
Jul 24, 2017
Initiates: Outperform
Price Target: n/a
Current: $1.60
Upside: -
Jun 12, 2017
Initiates: Outperform
Price Target: n/a
Current: $623.82
Upside: -